Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for nonalcoholic fatty liver disease in Chinese Han patients
ChiCTR-TRC-11001451Phase 4Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in metabolic dysfunction-associated steatotic liver disease (MASLD) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: liver biopsy. Started Sep 2011; status: completed.
02
Drugs
atorvastatin
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001451.